Clinical Trials Sponsored by Faeth Therapeutics
Total 6262 results
-
Promethera TherapeuticsCompletedUrea Cycle DisordersBelgium, Spain, France, Poland
-
Promethera TherapeuticsCompletedAcute-On-Chronic Liver FailureBelgium, France
-
RANI TherapeuticsCompletedHealthy VolunteersAustralia
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Musculoskeletal Diseases | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, DuchenneUnited States, Spain, Korea, Republic of, Belgium, France, Canada, Australia, United Kingdom, Israel, Italy, Brazil, Chile, Czechia, Sweden, Switzerland, Turkey, Germany, Poland
-
Halozyme TherapeuticsCompletedMetastatic Pancreatic CancerUnited States
-
Eleusis TherapeuticsCompleted
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Sangamo TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States
-
Blade TherapeuticsCompleted
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionKorea, Republic of, United States, Australia, Austria, Taiwan, China, Israel, Canada, India, Germany, Singapore, United Kingdom, Brazil, Italy, Netherlands, Argentina, Sweden, Chile, Denmark, France, Greece, Mexico, Poland
-
Corcept TherapeuticsCompletedCushing's SyndromeNetherlands, United States, Hungary, Italy, United Kingdom
-
Sangamo TherapeuticsCompletedHIV Infection | HIVUnited States
-
Corcept TherapeuticsCompleted
-
Celldex TherapeuticsCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Aprea TherapeuticsCompletedProstatic Neoplasms | Hematologic NeoplasmsSweden
-
Windtree TherapeuticsTerminatedRespiratory Distress SyndromeCanada, United States, Chile, Poland
-
Proteon TherapeuticsCompleted
-
BioMimetic TherapeuticsUnknownAnkle and Hindfoot Arthrodesis
-
PTC TherapeuticsWithdrawnDuchenne Muscular Dystrophy
-
Promethera TherapeuticsCompletedUrea Cycle Disorders | Crigler Najjar SyndromeBelgium
-
Cyclerion TherapeuticsCompletedHealthyUnited States
-
Akebia TherapeuticsCompletedHepatic ImpairmentUnited States
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Akebia TherapeuticsCompleted
-
Akebia TherapeuticsCompletedPharmacokinetics | Drug Interaction PotentiationCanada
-
Corcept TherapeuticsCompletedHealthyUnited Kingdom
-
Intarcia TherapeuticsTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
BioMimetic TherapeuticsCompletedFull Thickness Rotator Cuff TearCanada
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
Placon TherapeuticsUnknownBreast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States
-
United TherapeuticsCompleted
-
Agile TherapeuticsCompleted
-
BioMimetic TherapeuticsCompletedArthritis | Osteoarthritis | Rheumatoid Arthritis | Degenerative Joint Disease | Congenital DeformityUnited States, Canada
-
Heron TherapeuticsCompleted
-
Akebia TherapeuticsCompleted
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Halozyme TherapeuticsCompleted
-
Akebia TherapeuticsWithdrawnAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Therapeutics, Inc.Completed
-
Acorda TherapeuticsTerminatedRefractory EpilepsyUnited States
-
Fate TherapeuticsTerminatedMetabolic DisordersUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States